Edit Paper: Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking
From Murray Wiki
Jump to navigationJump to search
You do not have permission to edit this page, for the following reason: